{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:47:24Z","timestamp":1777895244362,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T00:00:00Z","timestamp":1509926400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10620-017-4828-z","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T07:34:11Z","timestamp":1509953651000},"page":"412-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association Between Small Intestinal Bacterial Overgrowth by Glucose Breath Test and Coronary Artery Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Andre","family":"Fialho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gursimran","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo L.","family":"Schenone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanti","family":"Thota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur J.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"4828_CR1","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association. Circulation. 2015;131:e29\u2013e322.","journal-title":"Circulation"},{"key":"4828_CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(98)10279-9","volume":"353","author":"DM Lloyd-Jones","year":"1999","unstructured":"Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89\u201392.","journal-title":"Lancet"},{"key":"4828_CR3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0002-9149(03)00717-3","volume":"92","author":"JL Georges","year":"2003","unstructured":"Georges JL, Rupprecht HJ, Blankenberg S, et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol. 2003;92:515\u2013521.","journal-title":"Am J Cardiol"},{"key":"4828_CR4","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","volume":"308","author":"PB Eckburg","year":"2005","unstructured":"Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635\u20131638.","journal-title":"Science"},{"key":"4828_CR5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576\u2013585.","journal-title":"Nat Med"},{"key":"4828_CR6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","volume":"35","author":"Z Wang","year":"2014","unstructured":"Wang Z, Tang WH, Buffa JA, et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur Heart J. 2014;35:904\u2013910.","journal-title":"Eur Heart J"},{"key":"4828_CR7","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575\u20131584.","journal-title":"N Engl J Med"},{"key":"4828_CR8","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.3748\/wjg.v13.45.6016","volume":"13","author":"I Esposito","year":"2007","unstructured":"Esposito I, de Leone A, Di Gregorio G, et al. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics. World J Gastroenterol. 2007;13:6016\u20136021.","journal-title":"World J Gastroenterol"},{"key":"4828_CR9","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143\u20133421.","journal-title":"Circulation"},{"key":"4828_CR10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCINTERVENTIONS.109.879312","volume":"2","author":"K Dosh","year":"2009","unstructured":"Dosh K, Berger PB, Marso S, et al. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial. Circ Cardiovasc Interv. 2009;2:503\u2013512.","journal-title":"Circ Cardiovasc Interv"},{"key":"4828_CR11","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1001\/jama.286.17.2107","volume":"286","author":"E Lindmark","year":"2001","unstructured":"Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA. 2001;286:2107\u20132113.","journal-title":"JAMA"},{"key":"4828_CR12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000155614.35441.69","volume":"111","author":"M Valgimigli","year":"2005","unstructured":"Valgimigli M, Ceconi C, Malagutti P, et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation. 2005;111:863\u2013870.","journal-title":"Circulation"},{"key":"4828_CR13","first-page":"3","volume":"52","author":"M Kowalski","year":"2001","unstructured":"Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol. 2001;52:3\u201331.","journal-title":"J Physiol Pharmacol"},{"key":"4828_CR14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.freeradbiomed.2011.02.018","volume":"50","author":"P Bullon","year":"2011","unstructured":"Bullon P, Cordero MD, Quiles JL, Morillo JM, del Carmen Ramirez-Tortosa M, Battino M. Mitochondrial dysfunction promoted by Porphyromonas gingivalis lipopolysaccharide as a possible link between cardiovascular disease and periodontitis. Free Radic Biol Med. 2011;50:1336\u20131343.","journal-title":"Free Radic Biol Med"},{"key":"4828_CR15","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0735-1097(01)01291-8","volume":"37","author":"V Mathew","year":"2001","unstructured":"Mathew V, Farkouh M, Grill DE, et al. Clinical risk stratification correlates with the angiographic extent of coronary artery disease in unstable angina. J Am Coll Cardiol. 2001;37:2053\u20132058.","journal-title":"J Am Coll Cardiol"},{"key":"4828_CR16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0016-5085(90)90818-L","volume":"98","author":"GR Corazza","year":"1990","unstructured":"Corazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990;98:302\u2013309.","journal-title":"Gastroenterology"},{"key":"4828_CR17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1365-2036.2011.04625.x","volume":"33","author":"RS Choung","year":"2011","unstructured":"Choung RS, Ruff KC, Malhotra A, et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011;33:1059\u20131067.","journal-title":"Aliment Pharmacol Ther"},{"key":"4828_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000007753","volume":"61","author":"PO Stotzer","year":"2000","unstructured":"Stotzer PO, Kilander AF. Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion. 2000;61:165\u2013171.","journal-title":"Digestion"},{"key":"4828_CR19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1365-2036.2005.02690.x","volume":"22","author":"A Lupascu","year":"2005","unstructured":"Lupascu A, Gabrielli M, Lauritano EC, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case\u2013control study in irritable bowel syndrome. Aliment Pharmacol Ther. 2005;22:1157\u20131160.","journal-title":"Aliment Pharmacol Ther"},{"key":"4828_CR20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/dia.2011.0078","volume":"13","author":"S Rana","year":"2011","unstructured":"Rana S, Bhansali A, Bhadada S, Sharma S, Kaur J, Singh K. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India. Diabetes Technol Ther. 2011;13:1115\u20131120.","journal-title":"Diabetes Technol Ther"},{"key":"4828_CR21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11695-007-9398-2","volume":"18","author":"JM Sabate","year":"2008","unstructured":"Sabate JM, Jouet P, Harnois F, et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg. 2008;18:371\u2013377.","journal-title":"Obes Surg"},{"key":"4828_CR22","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s10620-010-1447-3","volume":"56","author":"AA Shanab","year":"2011","unstructured":"Shanab AA, Scully P, Crosbie O, et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci. 2011;56:1524\u20131534.","journal-title":"Dig Dis Sci"},{"key":"4828_CR23","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s11695-007-9243-7","volume":"17","author":"AG Ruiz","year":"2007","unstructured":"Ruiz AG, Casafont F, Crespo J, et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg. 2007;17:1374\u20131380.","journal-title":"Obes Surg"},{"key":"4828_CR24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/gut.2006.108712","volume":"56","author":"I Posserud","year":"2007","unstructured":"Posserud I, Stotzer PO, Bjornsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007;56:802\u2013808.","journal-title":"Gut"},{"key":"4828_CR25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MCG.0b013e3181557e67","volume":"43","author":"A Rubio-Tapia","year":"2009","unstructured":"Rubio-Tapia A, Barton SH, Rosenblatt JE, Murray JA. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol. 2009;43:157\u2013161.","journal-title":"J Clin Gastroenterol"},{"key":"4828_CR26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2009.03994.x","volume":"29","author":"C Pande","year":"2009","unstructured":"Pande C, Kumar A, Sarin SK. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther. 2009;29:1273\u20131281.","journal-title":"Aliment Pharmacol Ther"},{"key":"4828_CR27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/apt.12304","volume":"37","author":"C Jacobs","year":"2013","unstructured":"Jacobs C, Coss Adame E, Attaluri A, Valestin J, Rao SS. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth. Aliment Pharmacol Ther. 2013;37:1103\u20131111.","journal-title":"Aliment Pharmacol Ther"},{"key":"4828_CR28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.23566","volume":"26","author":"M Gabrielli","year":"2011","unstructured":"Gabrielli M, Bonazzi P, Scarpellini E, et al. Prevalence of small intestinal bacterial overgrowth in Parkinson\u2019s disease. Mov Disord. 2011;26:889\u2013892.","journal-title":"Mov Disord"},{"key":"4828_CR29","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.25522","volume":"28","author":"A Fasano","year":"2013","unstructured":"Fasano A, Bove F, Gabrielli M, et al. The role of small intestinal bacterial overgrowth in Parkinson\u2019s disease. Mov Disord. 2013;28:1241\u20131249.","journal-title":"Mov Disord"},{"key":"4828_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57\u201363.","journal-title":"Nature"},{"key":"4828_CR31","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","volume":"49","author":"L Miele","year":"2009","unstructured":"Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49:1877\u20131887.","journal-title":"Hepatology"},{"key":"4828_CR32","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.ATV.20.6.1536","volume":"20","author":"RA Memon","year":"2000","unstructured":"Memon RA, Staprans I, Noor M, et al. Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol. 2000;20:1536\u20131542.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4828_CR33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11894-015-0482-9","volume":"18","author":"A Rezaie","year":"2016","unstructured":"Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18:8.","journal-title":"Curr Gastroenterol Rep"},{"key":"4828_CR34","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F Backhed","year":"2004","unstructured":"Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718\u201315723.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4828_CR35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","volume":"457","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480\u2013484.","journal-title":"Nature"},{"key":"4828_CR36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"FH Karlsson","year":"2013","unstructured":"Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498:99\u2013103.","journal-title":"Nature"},{"key":"4828_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55\u201360.","journal-title":"Nature"},{"key":"4828_CR38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature14232","volume":"519","author":"B Chassaing","year":"2015","unstructured":"Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519:92\u201396.","journal-title":"Nature"},{"key":"4828_CR39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000336174","volume":"85","author":"SV Rana","year":"2012","unstructured":"Rana SV, Sharma S, Kaur J, Sinha SK, Sing K. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion. 2012;85:243\u2013247.","journal-title":"Digestion"},{"key":"4828_CR40","doi-asserted-by":"publisher","first-page":"3230859","DOI":"10.1155\/2016\/3230859","volume":"2016","author":"H Chu","year":"2016","unstructured":"Chu H, Fox M, Zheng X, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome: clinical characteristics, psychological factors, and peripheral cytokines. Gastroenterol Res Pract. 2016;2016:3230859. https:\/\/doi.org\/10.1155\/2016\/3230859 .","journal-title":"Gastroenterol Res Pract"},{"key":"4828_CR41","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1365-2982.2008.01142.x","volume":"20","author":"M Grover","year":"2008","unstructured":"Grover M, Kanazawa M, Palsson OS, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil. 2008;20:998\u20131008.","journal-title":"Neurogastroenterol Motil"},{"key":"4828_CR42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/gut.2006.108712","volume":"56","author":"I Posserud","year":"2007","unstructured":"Posserud I, Stotzer PO, Bj\u00f6rnsson ES, Abrahamsson H, Simren M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007;56:802\u2013808.","journal-title":"Gut"},{"key":"4828_CR43","first-page":"6","volume":"25","author":"UC Ghoshal","year":"2006","unstructured":"Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol. 2006;25:6\u201310.","journal-title":"Indian J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-017-4828-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4828-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-017-4828-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T17:10:41Z","timestamp":1570295441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-017-4828-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4828"],"URL":"https:\/\/doi.org\/10.1007\/s10620-017-4828-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,6]]}}}